Nktr stock price yahoo
Nektar Therapeutics's stock rating is based on fundamental analysis. Don't miss NKTR stock next rating changes NKTR -- Is Its Stock Price A Worthy Investment? Learn More. NKTR Stock Summary. Of note is the ratio of Nektar Therapeutics's sales and general administrative expense to its total operating expenses; just 8.58% of US stocks have a lower such ratio. With a price/sales ratio of 26.12, Nektar Therapeutics has a higher such ratio than 95.86% of stocks in our set.